Acquisition / mergerNotableFiled on BSE ·

JB Chemicals & Pharmaceuticals Ltd files shareholding and scheme compliance reports

J B Chemicals & Pharmaceuticals · Pharmaceuticals & Biotechnology

Arthneeti Research DeskPublished 1 min read

Key highlights

  • JB Chemicals & Pharmaceuticals Ltd submitted shareholding pattern as on 31/03/2025 with no partly paid shares, convertible securities, warrants, or pledged promoter shares; locked-in shares exist.
  • The scheme of amalgamation with Torrent Pharmaceuticals Limited includes fairness opinion by ICICI Securities dated 29 June 2025 confirming share exchange ratio; necessary regulatory observations incorporated.
  • Multiple complaints reports from Oct-Dec 2025 and Jul-Dec 2025 periods show no complaints received or pending regarding the scheme or company actions.

Why it's rated notable: The merger is sized like an acquisition, but the filing states no rupee value and the scheme is non-binding until shareholder vote, Tribunal sanction and regulatory approvals, so the level is medium.

Original filing

Notice For NCLT Convened Meeting Of Equity Shareholders

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from J B Chemicals & Pharmaceuticals

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.